Ricardo Rayas joined the team in July 2022 to support investigations of novel vascular disrupting agents in therapeutic combinations to treat kidney cancer. Ricardo is a UT Austin alumni with a strong background in cell culture and instrumentation. He takes over Regan Schuetze position who gained a place in the MD/PhD program at UTMB Galveston following two years in the lab. Ricardo enjoys learning new skills and performing music on his spare time.